References: Surgical management of arthroplasty device infections

  • Aalirezaie A, Bauer TW, Fayaz H, Griffin W, Higuera CA, Krenn V, et al. Hip and Knee Section, Diagnosis, Reimplantation: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty 2019;34(2S):S369-S79. https://www.ncbi.nlm.nih.gov/pubmed/30343965
  • Ascione T, Balato G, Mariconda M, Rotondo R, Baldini A, Pagliano P. Continuous Antibiotic Therapy Can Reduce Recurrence of Prosthetic Joint Infection in Patients Undergoing 2-Stage Exchange. J Arthroplasty 2019;34(4):704-9. https://www.ncbi.nlm.nih.gov/pubmed/30665833
  • Ascione T, Balato G, Mariconda M, Smeraglia F, Baldini A, De Franco C, et al. Synovial Cell Count Before Reimplantation Can Predict the Outcome of Patients with Periprosthetic Knee Infections Undergoing Two-stage Exchange. Clin Orthop Relat Res 2021;479(9):2061-8. https://www.ncbi.nlm.nih.gov/pubmed/33944811
  • Bernard L, Arvieux C, Brunschweiler B, Touchais S, Ansart S, Bru JP, et al. Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection. N Engl J Med 2021;384(21):1991-2001. https://www.ncbi.nlm.nih.gov/pubmed/34042388
  • Davis JS, Metcalf S, Clark B, Robinson JO, Huggan P, Luey C, et al. Predictors of Treatment Success After Periprosthetic Joint Infection: 24-Month Follow up From a Multicenter Prospective Observational Cohort Study of 653 Patients. Open Forum Infect Dis 2022;9(3):ofac048. https://www.ncbi.nlm.nih.gov/pubmed/35233433
  • de Beaubien B, Belden K, Bell K, Boyle KK, Cordero-Ampuero J, Della Valle CJ, et al. Hip and Knee Section, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty 2019;34(2S):S477-S82. https://www.ncbi.nlm.nih.gov/pubmed/30348565
  • Frank JM, Kayupov E, Moric M, Segreti J, Hansen E, Hartman C, et al. The Mark Coventry, MD, Award: Oral Antibiotics Reduce Reinfection After Two-Stage Exchange: A Multicenter, Randomized Controlled Trial. Clin Orthop Relat Res 2017;475(1):56-61. https://www.ncbi.nlm.nih.gov/pubmed/27387759
  • Haasper C, Buttaro M, Hozack W, Aboltins CA, Borens O, Callaghan JJ, et al. Irrigation and debridement. J Arthroplasty 2014;29(2 Suppl):100-3. https://www.ncbi.nlm.nih.gov/pubmed/24360491
  • Konan S, Frommelt L, Lausmann C, Gehrke T, Volpin A. What is the recommended duration of antibiotics after a single-stage exchange for periprosthetic joint infections (PJIs)? In: Proceedings of the Second International Consensus Meeting on Musculoskeletal Infection; 25-27 July 2018, Philadelphia Brooklandville, Maryland: Data Trace Publishing Company; 2018. p. 481-2. https://icmphilly.com/questions/what-is-the-recommended-duration-of-antibiotics-after-a-single-stage-exchange-for-periprosthetic-joint-infections-pjis/
  • Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, Sanchez-Somolinos M, Baraia-Etxaburu JM, et al. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis 2013;56(2):182-94. https://www.ncbi.nlm.nih.gov/pubmed/22942204
  • Manning L, Metcalf S, Clark B, Robinson JO, Huggan P, Luey C, et al. Clinical Characteristics, Etiology, and Initial Management Strategy of Newly Diagnosed Periprosthetic Joint Infection: A Multicenter, Prospective Observational Cohort Study of 783 Patients. Open Forum Infect Dis 2020;7(5):ofaa068. https://www.ncbi.nlm.nih.gov/pubmed/32432148
  • Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2013;56(1):e1-e25. https://www.ncbi.nlm.nih.gov/pubmed/23223583
  • Sandiford NA, McHale A, Citak M, Kendoff D. What is the optimal duration of intravenous antibiotics following single-stage revision total hip arthroplasty for prosthetic joint infection? A systematic review. Hip Int 2021;31(3):286-94. https://www.ncbi.nlm.nih.gov/pubmed/32459114
  • Wouthuyzen-Bakker M, Ebied A, Hyonmin C, Shohat N, Sameh M. What are the indications and contraindications of using debridement, antibiotics and implant retention (DAIR) with exchange of modular components for the management of periprosthetic joint infection (PJI)? In: Proceedings of the Second International Consensus Meeting on Musculoskeletal Infection; 25-27 July 2018, Philadelphia. Brooklandville, Maryland: Data Trace Publishing Company; 2018. p. 412-4. https://icmphilly.com/questions/what-are-the-indications-and-contraindications-of-using-debridement-antibiotics-and-implant-retention-dair-with-exchange-of-modular-components-for-the-management-of-periprosthetic-joint-infection/
  • Wouthuyzen-Bakker M, Sebillotte M, Huotari K, Escudero Sanchez R, Benavent E, Parvizi J, et al. Lower Success Rate of Debridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study. Clin Orthop Relat Res 2020;478(6):1348-55. https://www.ncbi.nlm.nih.gov/pubmed/32106134
  • Xu C, Tan TL, Chen JY. Positive Culture During Reimplantation Increases the Risk of Reinfection in Two-Stage Exchange Arthroplasty Despite Administrating Prolonged Antibiotics: A Retrospective Cohort Study and Meta-Analysis. J Arthroplasty 2019;34(5):1025-31. https://www.ncbi.nlm.nih.gov/pubmed/30773359